NGFR and neoplasm: Antibody-mediated targeting of CD271+ melanoma cells has recently been shown to synergize with the activation of an innate immune response via CD47 blockade and dramatically reduce tumor growth, as well as, the lymph node and distant organ metastases in mice xenotransplanted with patient derived melanomas9.